- Advertise
- Contact Us
- Contribute
- Editorial Info
- Terms and Conditions
- Privacy Policy
- Do Not Sell My Personal Information
- About Us
© 2021 MJH Life Sciences™ and Endocrinology Network. All rights reserved.
Thyroid Disorders
The Endocrinology Network® Thyroid Disorders clinical resource center offers readers insight and perspective into the latest from management of hypothyroidism, hyperthyroidism, thyroid cancers, and other thyroid disorders. One of the most common disorders seen by endocrinologists and those practicing in endocrinology, our thyroid disorders resource center hosts content related to FDA approvals, the latest studies, and guideline updates in management of thyroid disorders.
Endocrine Case Report: Swollen Glands
November 29, 2021
The latest endocrine case report from Brady Pregerson, MD, features a woman in her mid-30s presenting with swollen glands lasting for the past 3 days and an associated sore throat. Can you determine the correct diagnosis?
Thyroid Ablation in Operating Rooms Result in Fewer Side Effects Than Ambulatory Settings
October 08, 2021
An analysis of nearly 400 patients suggests undergoing thyroid radiofrequency ablation in ambulatory settings was associated with increased risk of intraoperative, postoperative, and perioperative side effects than those performed in operating room settings.
ATA Study Details Risk Factors, Comorbidities Associated with Severe Thyroid Eye Disease
October 07, 2021
An analysis of more than 650 thyroid eye disease patients is providing clinicians with insight into the most common comorbidities and risk factors associated with increased disease severity in patients with TED.
Teprotumumab Proves Benefit in Longer Duration Thyroid Eye Disease
October 06, 2021
An analysis of data from OPTIC and OPTIC-X provide insight into the effects of teprotumumab in longer duration thyroid eye disease and among patients who were nonresponders in the original trial.
Proton Pump Inhibitors Do Not Interfere with Absorption of Tirosint-SOL
October 05, 2021
Results of a bioavailability, crossover study suggest use of proton pump inhibitors did not interfere with the absorption of levothyroxine sodium oral solution.
Study Details Impact of Diabetes on Disease Presentation Among Patients with Thyroid Eye Disease
June 02, 2021
Analysis of claims data from the Symphony database offers clinicians greater insight into the impact of diabetes, both type 1 and type 2, on thyroid eye disease in US patients.
AACE 2021 Analysis Details Risk of Cardiovascular Disease, AFib, and CV Death in Thyroid Cancer Patients
June 02, 2021
A systematic review and meta-analysis presented at AACE 2021 details the risk of cardiovascular disease in patients with thyroid cancer who have undergone thyroidectomy.
Phase 1 Trial Indicates Liquid Formulation of Levothyroxine Safe to Administer as Early as 15 Minutes Before Breakfast
June 01, 2021
Data from a phase 1 trial comparing dosing 15 and 30 minutes prior to breakfast suggests the wait time between intake of the novel liquid formulation of levothyroxine, Tirosint-SOL, and breakfast could be shortened to 15 minutes.
COVID-19 Could Cause Atypical Thyroid Inflammation
March 24, 2021
A study from ENDO 2021 indicates moderate-to-severe COVID-19 infections are associated with atypical thyroid inflammation.
Thyroid Combination Therapy Preferred Over Levothyroxine for Some Hypothyroidism Patients
March 21, 2021
A randomized, 3-arm study is giving further insight into the effects of levothyroxine monotherapy compared against a thyroid combination therapy and desiccated thyroid extract for management of hypothyroidism, particularly in patients with Thr92AlaD2 polymorphism.